Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...
LA JOLLA - GRI Bio, Inc. (NASDAQ:GRI) announced Wednesday that its Phase 2a clinical trial evaluating GRI-0621 for idiopathic pulmonary fibrosis (IPF) met both primary and secondary endpoints. The ...
Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. It's a worst-case scenario, you dropped your shiny new laptop and the damage isn't covered by the ...
Do you need to repay your PPP loan? Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback